Submitted by comunicaciones on Thu, 05/22/2025 - 11:36
ECBE
ECBE leiomiomatosis uterina en pacientes sintomáticas
seccion ECBE
Referencias
Body
  1. Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun JL, De Jesus I, et al. Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur J Obstet Gynecol Reprod Biol. diciembre de 2012;165(2):156–64.
  2. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet Gynecol. el 1 de junio de 2021;137(6):e100–15.
  3. Munro MG, Critchley HOD, Broder MS, Fraser IS, Disorders for the FWG on M. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet. 2011;113(1):3–13.
  4. Stewart E, Cookson C, Gandolfo R, Schulze‐Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG Int J Obstet Gynaecol. septiembre de 2017;124(10):1501–12.
  5. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. enero de 2003;188(1):100–7.
  6. Eltoukhi HM, Modi MN, Weston M, Armstrong AY, Stewart EA. The health disparities of uterine fibroid tumors for African American women: a public health issue. Am J Obstet Gynecol. marzo de 2014;210(3):194–9.
  7. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. el 1 de enero de 2018;46:3–11.
  8. Leonardi M, Robledo KP, Gordijn SJ, Condous G. A consensus-based core feature set for surgical complexity at laparoscopic hysterectomy. Am J Obstet Gynecol. el 1 de mayo de 2022;226(5):700.e1-700.e9.
  9. Singh S, Best C, Dunn S, Leyland N, Wolfman WL. No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. mayo de 2018;40(5):e391–415.
  10. 1Brouwers MC, Kerkvliet K, Spithoff K, AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. el 8 de marzo de 2016;352:i1152.
  11. Vilos GA, Allaire C, Laberge PY, Leyland N, Vilos AG, Murji A, et al. The Management of Uterine Leiomyomas. J Obstet Gynaecol Can. febrero de 2015;37(2):157–78.
  12. Hospital Universitario Nacional de Colombia, Universidad Nacional de Colombia. DIAGNÓSTICO Y TRATAMIENTO SINTOMÁTICO DE LA PACIENTE CON HEMORRAGIA UTERINA ANORMAL EN EL HOSPITAL UNIVERSITARIO NACIONAL DE COLOMBIA [Internet]. Disponible en: https://www.hun.edu.co/sites/default/files/2024-07/02_16_ECBE_DARUMA%20HUA.pdf
  13. Van Den Bosch T, Dueholm M, Leone FPG, Valentin L, Rasmussen CK, Votino A, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. septiembre de 2015;46(3):284–98.
  14. Benacerraf BR, Abuhamad AZ, Bromley B, Goldstein SR, Groszmann Y, Shipp TD, et al. Consider ultrasound first for imaging the female pelvis. Am J Obstet Gynecol. el 1 de abril de 2015;212(4):450–5.
  15. Lasmar RB, Lasmar BP, Celeste RK, Da Rosa DB, Depes DDB, Lopes RGC. A New System to Classify Submucous Myomas: A Brazilian Multicenter Study. J Minim Invasive Gynecol. septiembre de 2012;19(5):575–80.
  16. Hindman N, Kang S, Fournier L, Lakhman Y, Nougaret S, Reinhold C, et al. MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement. Radiology. el 4 de octubre de 2022;306(2):e211658.
  17. Andersen LL, Alling Møller LM, Gimbel HM. Objective comparison of subtotal vs. total abdominal hysterectomy regarding pelvic organ prolapse and urinary incontinence: a randomized controlled trial with 14-year follow-up. Eur J Obstet Gynecol Reprod Biol. octubre de 2015;193:40–5.
  18. Doyle DJ, Hendrix JM, Garmon EH. American Society of Anesthesiologists Classification. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [citado el 13 de agosto de 2024]. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK441940/
  19. Loddo A, Djokovic D, Drizi A, Vree BPD, Sedrati A, Herendael BJ van. Hysteroscopic myomectomy: The guidelines of the International Society for Gynecologic Endoscopy (ISGE). Eur J Obstet Gynecol Reprod Biol. el 1 de enero de 2022;268:121–8.
  20. Kaganov H, Ades A, Fraser DS. PREOPERATIVE MAGNETIC RESONANCE IMAGING DIAGNOSTIC FEATURES OF UTERINE LEIOMYOSARCOMAS: A SYSTEMATIC REVIEW. Int J Technol Assess Health Care. enero de 2018;34(2):172–9.
  21. Orlando M, Kollikonda S, Hackett L, Kho R. Non-hysteroscopic Myomectomy and Fertility Outcomes: A Systematic Review. J Minim Invasive Gynecol. el 1 de marzo de 2021;28(3):598-618.e1.
  22. Metwally M, Raybould G, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility - Metwally, M - 2020 | Cochrane Library. [citado el 13 de agosto de 2024]; Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003857.pub4/full
  23. Carranza-Mamane B, Havelock J, Hemmings R, Cheung A, Sierra S, Case A, et al. The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility. J Obstet Gynaecol Can. el 1 de marzo de 2015;37(3):277–85.
  24. Cianci S, Gulino FA, Palmara V, La Verde M, Ronsini C, Romeo P, et al. Exploring Surgical Strategies for Uterine Fibroid Treatment: A Comprehensive Review of Literature on Open and Minimally Invasive Approaches. Medicina (Mex). el 28 de diciembre de 2023;60(1):64.
  25. Chittawar PB, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids - Bhave Chittawar, P - 2014 | Cochrane Library. [citado el 13 de agosto de 2024]; Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004638.pub3/full
  26. Murji A, Scott S, Singh SS, Bougie O, Leyland N, Laberge PY, et al. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy. J Obstet Gynaecol Can. el 1 de enero de 2019;41(1):116–26.
  27. Thurston J, Murji A, Scattolon S, Wolfman W, Kives S, Sanders A, et al. No. 377-Hysterectomy for Benign Gynaecologic Indications. J Obstet Gynaecol Can. el 1 de abril de 2019;41(4):543–57.
  28. Glasser MH. Minilaparotomy: A Minimally Invasive Alternative for Major Gynecologic Abdominal Surgery. Perm J. 2005;9(1):41–5.
  29. Millet P, Gauthier T, Vieillefosse S, Dewaele P, Rivain AL, Legendre G, et al. Should we perform cervix removal during hysterectomy for benign uterine disease? Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF). J Gynecol Obstet Hum Reprod. el 1 de octubre de 2021;50(8):102134.
  30. Lethaby A, Ivanova V, Johnson N. Total versus subtotal hysterectomy for benign gynaecological conditions - Lethaby, A - 2006 | Cochrane Library. [citado el 14 de agosto de 2024]; Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004993.pub2/information
  31. Drug Interactions results - MICROMEDEX [Internet]. [citado el 14 de agosto de 2024]. Disponible en: https://www-micromedexsolutions-com.udea.lookproxy.com/micromedex2/librarian/PFDefaultActionId/evidencexpert.ShowDrugInteractionsResults
  32. Lethaby A, Puscasiu L, Vollenhoven B. Preoperative medical therapy before surgery for uterine fibroids - Lethaby, A - 2017 | Cochrane Library. [citado el 14 de agosto de 2024]; Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000547.pub2/full
  33. Wilson AC, Vadakkadath Meethal S, Bowen RL, Atwood CS. Leuprolide acetate: a drug of diverse clinical applications. Expert Opin Investig Drugs. el 1 de noviembre de 2007;16(11):1851–63.
  34. INVIMA M. Informe de Seguridad No. 066-2019 Riesgo potencial de daño hepático con el uso de acetato de ulipristal [Internet]. 2019. Disponible en: https://app.invima.gov.co/alertas/ckfinder/userfiles/files/INFORMES%20DE%20SEGURIDAD/Medicamentos/2019/MARZO/Informe%20de%20seguridad%20No_%20%23066-2019%20.pdf
  35. Karlsen K, Hrobjartsson A, Korsholm M, Mogensen O, Humaidan P, Ravn P. Fertility after uterine artery embolization of fibroids: a systematic review. Arch Gynecol Obstet. el 1 de enero de 2018;297(1):13–25.
  36. khatova A, Aimagambetova G, Bapayeva G, Laganà AS, Chiantera V, Oppelt P, et al. Reproductive and Obstetric Outcomes after UAE, HIFU, and TFA of Uterine Fibroids: Systematic Review and Meta-Analysis. Int J Environ Res Public Health. el 2 de marzo de 2023;20(5):4480.
  37. Ilott I, Rick J, Patterson M, Turgoose C, Lacey A. What is protocol-based care? A concept analysis. J Nurs Manag. octubre de 2006;14(7):544–52.
  38. Gulwani S. Programming by Examples: Applications, Algorithms, and Ambiguity Resolution.
  39. Jun GT, Ward J, Morris Z, Clarkson J. Health care process modelling: which method when? Int J Qual Health Care. el 1 de junio de 2009;21(3):214–24.
  40. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. el 29 de marzo de 2021;n71.
  41. ACOG practice bulletin-Surgical Alternatives to Hysterectomy in the Management of Leiomyomas. Int J Gynecol Obstet. 2001;73(3):285–94.